Scandidos
1.06 SEK
-1.40 %
Less than 1K followers
SDOS
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.40 %
-2.31 %
-15.94 %
-26.99 %
-41.39 %
-39.02 %
-60.19 %
-63.75 %
-92.37 %
Scandidos operates in the medical technology sector. The company offers products and systems for quality assurance of advanced radiation therapy for cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Read moreMarket cap
60.15M SEK
Turnover
7.75K SEK
Revenue
61.84M
EBIT %
0.99 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
16/12
2025
Interim report Q2'26
18/3
2026
Interim report Q3'26
17/6
2026
Annual report '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
Scandidos informerar om att Spore Invest AB har passerat gränsen för budplikt
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I SCANDIDOS AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools